Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs4374383
rs4374383
MERTK
0.710 GeneticVariation BEFREE <i>MERTK</i> rs4374383 A carriers had a lower risk of liver fibrosis progression than G carriers, supporting the hypothesis that this SNP seems to have a critical role in the pathogenesis of liver disease in HCV-infected patients. 30477195

2018
dbSNP: rs4374383
rs4374383
MERTK
A 0.710 GeneticVariation GWASCAT In the combined cohort of 2342 HCV-infected patients, the SNPs rs16851720 (in the total sample) and rs4374383 (in patients who received blood transfusions) were associated with fibrosis progression (P(combined) = 8.9 × 10(-9) and 1.1 × 10(-9), respectively). 22841784

2012
dbSNP: rs116399066
rs116399066 		0.700 GeneticVariation GWASCAT Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients. 31260374

2019
dbSNP: rs11790131
rs11790131
LOC105375988
0.700 GeneticVariation GWASCAT A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients. 27339598

2016
dbSNP: rs13401937
rs13401937
RTN4
0.700 GeneticVariation GWASCAT Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients. 31260374

2019
dbSNP: rs143633948
rs143633948
ARG1
0.700 GeneticVariation GWASCAT A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients. 27339598

2016
dbSNP: rs16851720
rs16851720
RNF7
C 0.700 GeneticVariation GWASCAT In the combined cohort of 2342 HCV-infected patients, the SNPs rs16851720 (in the total sample) and rs4374383 (in patients who received blood transfusions) were associated with fibrosis progression (P(combined) = 8.9 × 10(-9) and 1.1 × 10(-9), respectively). 22841784

2012
dbSNP: rs1754257
rs1754257
GPR158
A 0.700 GeneticVariation GWASCAT Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus. 30593799

2019
dbSNP: rs2492965
rs2492965 		0.700 GeneticVariation GWASCAT Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients. 31260374

2019
dbSNP: rs2629751
rs2629751
GLT8D2
G 0.700 GeneticVariation GWASCAT Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection. 22841784

2012
dbSNP: rs2647006
rs2647006 		C 0.700 GeneticVariation GWASCAT Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus. 30593799

2019
dbSNP: rs2647051
rs2647051 		C 0.700 GeneticVariation GWASCAT Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus. 30593799

2019
dbSNP: rs2856723
rs2856723 		0.700 GeneticVariation GWASCAT Human leukocyte antigen variants and risk of hepatocellular carcinoma modified by hepatitis C virus genotypes: A genome-wide association study. 28921602

2018
dbSNP: rs2978048
rs2978048 		0.700 GeneticVariation GWASCAT Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor. 24503447

2014
dbSNP: rs35384524
rs35384524
NCAM2
0.700 GeneticVariation GWASCAT Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients. 31260374

2019
dbSNP: rs35467001
rs35467001
SDK2
0.700 GeneticVariation GWASCAT A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients. 27339598

2016
dbSNP: rs35897606
rs35897606
KIAA1549L
0.700 GeneticVariation GWASCAT A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients. 27339598

2016
dbSNP: rs4803221
rs4803221
IFNL4
0.700 GeneticVariation GWASCAT Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients. 31260374

2019
dbSNP: rs56378326
rs56378326
PKIB
0.700 GeneticVariation GWASCAT Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients. 31260374

2019
dbSNP: rs59888390
rs59888390 		0.700 GeneticVariation GWASCAT Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients. 31260374

2019
dbSNP: rs62042908
rs62042908
LOC105370982
0.700 GeneticVariation GWASCAT Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients. 31260374

2019
dbSNP: rs6445096
rs6445096
SPATA16
0.700 GeneticVariation GWASCAT Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients. 31260374

2019
dbSNP: rs7262634
rs7262634 		0.700 GeneticVariation GWASCAT Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor. 24503447

2014
dbSNP: rs72799981
rs72799981
ARHGAP26
0.700 GeneticVariation GWASCAT Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients. 31260374

2019
dbSNP: rs73084982
rs73084982
LOC105372508
0.700 GeneticVariation GWASCAT A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients. 27339598

2016